CD70, which is a cytokine belonging to the tumor necrosis factor ligand family, is also a prognostic marker for pancreatic cancer (41) and a potential therapeutic target for pancreatic cancer (42). This evidence concerns the gene CD70 and pancreatic neoplasm.